Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury

We previously found that argon exerts its neuroprotective effect in part by inhibition of the toll-like receptors (TLR) 2 and 4. The downstream transcription factors signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NF-κB) are also affected by argon and may play...

Full description

Bibliographic Details
Main Authors: Ulrich Goebel, Stefanie Scheid, Sashko Spassov, Nils Schallner, Jakob Wollborn, Hartmut Buerkle, Felix Ulbrich
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=1;spage=192;epage=198;aulast=Goebel
_version_ 1818995177301213184
author Ulrich Goebel
Stefanie Scheid
Sashko Spassov
Nils Schallner
Jakob Wollborn
Hartmut Buerkle
Felix Ulbrich
author_facet Ulrich Goebel
Stefanie Scheid
Sashko Spassov
Nils Schallner
Jakob Wollborn
Hartmut Buerkle
Felix Ulbrich
author_sort Ulrich Goebel
collection DOAJ
description We previously found that argon exerts its neuroprotective effect in part by inhibition of the toll-like receptors (TLR) 2 and 4. The downstream transcription factors signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NF-κB) are also affected by argon and may play a role in neuroprotection. It also has been demonstrated that argon treatment could mitigate brain damage, reduce excessive microglial activation, and subsequently attenuate brain inflammation. Despite intensive research, the further exact mechanism remains unclear. In this study, human neuroblastoma cells were damaged in vitro with rotenone over a period of 4 hours (to mimic cerebral ischemia and reperfusion damage), followed by a 2-hour post-conditioning with argon (75%). In a separate in vivo experiment, retinal ischemia/reperfusion injury was induced in rats by increasing intraocular pressure for 1 hour. Upon reperfusion, argon was administered by inhalation for 2 hours. Argon reduced the binding of the transcription factors signal transducer and activator of transcription 3, nuclear factor kappa B, activator protein 1, and nuclear factor erythroid 2-related factor 2, which are involved in regulation of neuronal damage. Flow cytometry analysis showed that argon downregulated the Fas ligand. Some transcription factors were regulated by toll-like receptors; therefore, their effects could be eliminated, at least in part, by the TLR2 and TLR4 inhibitor oxidized phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC). Argon treatment reduced microglial activation after retinal ischemia/reperfusion injury. Subsequent quantitative polymerase chain reaction analysis revealed a reduction in the pro-inflammatory cytokines interleukin (IL-1α), IL-1β, IL-6, tumor necrosis factor α, and inducible nitric oxide synthase. Our results suggest that argon reduced the extent of inflammation in retinal neurons after ischemia/reperfusion injury by suppression of transcription factors crucial for microglial activation. Argon has no known side effects or narcotic properties; therefore, therapeutic use of this noble gas appears ideal for treatment of patients with neuronal damage in retinal ischemia/reperfusion injury. The animal experiments were approved by the Commission for Animal Care of the University of Freiburg (approval No. 35-9185.81/G14-122) on October 19, 2012.
first_indexed 2024-12-20T21:09:42Z
format Article
id doaj.art-b4df755a6a8849178e5c411abbfdb0ad
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-12-20T21:09:42Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-b4df755a6a8849178e5c411abbfdb0ad2022-12-21T19:26:32ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742021-01-0116119219810.4103/1673-5374.290098Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injuryUlrich GoebelStefanie ScheidSashko SpassovNils SchallnerJakob WollbornHartmut BuerkleFelix UlbrichWe previously found that argon exerts its neuroprotective effect in part by inhibition of the toll-like receptors (TLR) 2 and 4. The downstream transcription factors signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NF-κB) are also affected by argon and may play a role in neuroprotection. It also has been demonstrated that argon treatment could mitigate brain damage, reduce excessive microglial activation, and subsequently attenuate brain inflammation. Despite intensive research, the further exact mechanism remains unclear. In this study, human neuroblastoma cells were damaged in vitro with rotenone over a period of 4 hours (to mimic cerebral ischemia and reperfusion damage), followed by a 2-hour post-conditioning with argon (75%). In a separate in vivo experiment, retinal ischemia/reperfusion injury was induced in rats by increasing intraocular pressure for 1 hour. Upon reperfusion, argon was administered by inhalation for 2 hours. Argon reduced the binding of the transcription factors signal transducer and activator of transcription 3, nuclear factor kappa B, activator protein 1, and nuclear factor erythroid 2-related factor 2, which are involved in regulation of neuronal damage. Flow cytometry analysis showed that argon downregulated the Fas ligand. Some transcription factors were regulated by toll-like receptors; therefore, their effects could be eliminated, at least in part, by the TLR2 and TLR4 inhibitor oxidized phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC). Argon treatment reduced microglial activation after retinal ischemia/reperfusion injury. Subsequent quantitative polymerase chain reaction analysis revealed a reduction in the pro-inflammatory cytokines interleukin (IL-1α), IL-1β, IL-6, tumor necrosis factor α, and inducible nitric oxide synthase. Our results suggest that argon reduced the extent of inflammation in retinal neurons after ischemia/reperfusion injury by suppression of transcription factors crucial for microglial activation. Argon has no known side effects or narcotic properties; therefore, therapeutic use of this noble gas appears ideal for treatment of patients with neuronal damage in retinal ischemia/reperfusion injury. The animal experiments were approved by the Commission for Animal Care of the University of Freiburg (approval No. 35-9185.81/G14-122) on October 19, 2012.http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=1;spage=192;epage=198;aulast=Goebelargon; ischemia/reperfusion injury; microglia; neuroinflammation; neuroprotection; noble gas; sh-sy5y; toll-like receptor; transcription factor
spellingShingle Ulrich Goebel
Stefanie Scheid
Sashko Spassov
Nils Schallner
Jakob Wollborn
Hartmut Buerkle
Felix Ulbrich
Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury
Neural Regeneration Research
argon; ischemia/reperfusion injury; microglia; neuroinflammation; neuroprotection; noble gas; sh-sy5y; toll-like receptor; transcription factor
title Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury
title_full Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury
title_fullStr Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury
title_full_unstemmed Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury
title_short Argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia/reperfusion injury
title_sort argon reduces microglial activation and inflammatory cytokine expression in retinal ischemia reperfusion injury
topic argon; ischemia/reperfusion injury; microglia; neuroinflammation; neuroprotection; noble gas; sh-sy5y; toll-like receptor; transcription factor
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=1;spage=192;epage=198;aulast=Goebel
work_keys_str_mv AT ulrichgoebel argonreducesmicroglialactivationandinflammatorycytokineexpressioninretinalischemiareperfusioninjury
AT stefaniescheid argonreducesmicroglialactivationandinflammatorycytokineexpressioninretinalischemiareperfusioninjury
AT sashkospassov argonreducesmicroglialactivationandinflammatorycytokineexpressioninretinalischemiareperfusioninjury
AT nilsschallner argonreducesmicroglialactivationandinflammatorycytokineexpressioninretinalischemiareperfusioninjury
AT jakobwollborn argonreducesmicroglialactivationandinflammatorycytokineexpressioninretinalischemiareperfusioninjury
AT hartmutbuerkle argonreducesmicroglialactivationandinflammatorycytokineexpressioninretinalischemiareperfusioninjury
AT felixulbrich argonreducesmicroglialactivationandinflammatorycytokineexpressioninretinalischemiareperfusioninjury